Not available
Quote | Pulmatrix Inc. (NASDAQ:PULM)
Last: | $1.95 |
---|---|
Change Percent: | 0.4% |
Open: | $1.91 |
Close: | $1.95 |
High: | $1.96 |
Low: | $1.9001 |
Volume: | 3,525 |
Last Trade Date Time: | 06/17/2024 03:00:00 am |
News | Pulmatrix Inc. (NASDAQ:PULM)
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
2024-05-17 16:30:05 ET More on Pulmatrix Financial information for Pulmatrix Read the full article on Seeking Alpha For further details see: Pulmatrix files for $95M mixed shelf
Message Board Posts | Pulmatrix Inc. (NASDAQ:PULM)
Subject | By | Source | When |
---|---|---|---|
bears are running | Value_Investor | investorshub | 05/11/2023 2:25:52 AM |
Anyone hear anything lately? Want to see this one go | riskon | investorshub | 05/11/2023 1:55:09 AM |
$PULM MomentumIts gaining up | Value_Investor | investorshub | 05/09/2023 7:43:19 PM |
Price trading up | lakerol | investorshub | 05/08/2023 8:34:55 AM |
where is the squeeze? | makinezmoney | investorshub | 05/06/2023 4:35:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) PR Newswire Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intravenously (IV) a...